METHYL-AND TRIFLUOROMETHYL-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF

The present invention provides methyl-and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmac...

Full description

Saved in:
Bibliographic Details
Main Authors FLICK, ANDREW CHRISTOPHER, JONES, PETER, XING, LI, TRZUPEK, JOHN DAVID, WENNERSTÅL, GÖRAN MATTIAS, ZHANG, LIYING, ZAMARATSKI, EDOUARD, VAZQUEZ, MICHAEL L, KAILA, NEELU, MENTE, SCOT RICHARD, SCHNUTE, MARK EDWARD
Format Patent
LanguageEnglish
French
Published 31.03.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides methyl-and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating RORγ activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof. Cette invention concerne des pyrrolopyridines substitués par un méthyle et trifluorométhyle, des compositions pharmaceutiques les contenant, des procédés d'inhibition de l'activité de RORγ et/ou de réduction de la quantité d'IL-17 chez un sujet, ainsi que des méthodes de traitement de différents troubles médicaux à l'aide desdites pyrrolopyridines et desdites compositions pharmaceutiques les contenant.
Bibliography:Application Number: WO2015IB57314